Back

Impact of diabetes mellitus on the pharmacodynamic effects of ticagrelor versus clopidogrel in troponin-negative acute coronary syndrome patients undergoing ad-hoc percutaneous coronary intervention

30 August 2016 (10:33 - 10:40)
Organised by:
Congress Presentation Part of: Mechanisms of platelet activation Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Joseph Sweeny

New York City (United States of America)

6 More presentations in this session

Presentation thumbnail
Platelet responsiveness to PAR4 activation in a healthy population and its inhibition by a potent and selective PAR4 antagonist
Doctor K. Downes (Cambridge, GB)
Abstract
Presentation thumbnail
The platelet protease-activated receptor-4 antagonist, UDM-002555, alone and in combination with aspirin inhibits arterial thrombosis with limited impact on hemostasis in cynomolgus monkeys
Doctor P. Wong (Princeton, US)
Abstract Slides
Presentation thumbnail
Can off-pump coronary artery bypass graft surgery be performed 3 days after clopidogrel discontinuation without increasing the bleeding risk in acute coronary syndrome patients?
Mr W. Liu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Evaluation of immature platelet parameters as compared to established predictors of platelet reactivity after thienopyridine loading
Doctor C. Stratz (Bad Krozingen, DE)
Abstract Slides
Presentation thumbnail
Large mean platelet volume is associated with impaired clopidogrel-responsiveness in acute coronary syndrome patients, with no impact on prasugrel or ticagrelor effects
Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms of platelet activation

The Event

Event poster

ESC Congress 2016

30 August 2016 10:33 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources